FDA Warns Soon-Shiong Over Cancer Drug Claims
Dover News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Federal health officials issue warning to biotech billionaire Dr. Patrick Soon-Shiong for exaggerating claims about his companys bladder cancer drug, Anktiva. The FDA called out statements suggesting Anktiva could treat, cure, or prevent all types of cancers, which is misleading. The drug received approval for a tough-to-treat bladder cancer case, but promotions broke federal marketing rules. Company shares plunged after the warning, and ImmunityBio plans to work with the FDA to rectify the situation. This comes as the current administration intensifies scrutiny on drug companies and their media appearances.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/5c4bee11def42deb